Emapalumab's role in a severe and treatment-resistant paediatric macrophage activation syndrome
{{output}}
Introduction Macrophage activation syndrome (MAS) is a life-threatening hyperinflammatory condition. Emapalumab, an IFNγ-directed antibody, is approved for use in the USA but not in Europe. Case A 15-year-old girl presented with fever, odynophagia and a trans... ...
